Evidence map›Paper›PMID 35673688›Full record

ArticleIndian journal of palliative care

Morphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report.

Yukako Tanaka-Yagi, Takashi Yamaguchi, Yoshinobu Matsuda, Masanori Mori, Tomoo Ikari, Satoru Miwa, Kozue Suzuki, Ryo Tachikawa, Kyosuke Nakata, Masayuki Kanatani

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of palliative care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yukako Tanaka-YagiDepartment of Palliative Care, Konan Medical Center, Hyogo, Japan.
Takashi YamaguchiDepartment of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Yoshinobu MatsudaDepartment of Psychosomatic Internal Medicine, Kinki-Chuo Chest Medical Center, Sakai, Osaka, Japan.
Masanori MoriDepartment of Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan.
Tomoo IkariDepartment of Palliative Medicine, Tohoku University School of Medicine, Sendai, Miyagi, Japan.
Satoru MiwaDepartment of Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan.
Kozue SuzukiDepartment of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
Ryo TachikawaDepartment of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Kyosuke NakataDepartment of Palliative Care, Konan Medical Center, Hyogo, Japan.
Masayuki KanataniDepartment of Palliative Care, Konan Medical Center, Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, the world is undergoing successive waves of the COVID-19 pandemic. When COVID-19 becomes severe, it causes respiratory failure and symptoms of dyspnoea. The patient's dyspnoea worsens to the IPOS of 3. One COVID-19 patient admitted to our medical institution developed severe illness characterised by hypoxaemia and dyspnoea. In addition to disease-modifying treatments such as remdesivir and dexamethasone, we administered morphine to relieve his dyspnoea. Surprisingly, we observed an improvement in both hypoxaemia and dyspnoea.

Indexed as

COVID-19DyspnoeaMorphine

Identifiers

PMID35673688
PMCPMC9168286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.